drugset / Trial / NCT05661682

Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety

NCT05661682

Phase 4 Withdrawn American Regent, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

Tralement versus a fixed-dose trace element combination product of zinc, copper, and selenious acid to evaluate product safety in adult patients requiring long-term parenteral nutrition.

Timeline

Start
2025-02-01
Primary completion
2025-10-31
Completion
2026-12-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fixed-dose trace element combination product of zinc, copper, and selenious acid Unknown
Comparator Tralement Unknown

Indications

No indication recorded.